CSS LLC’s Lisata Therapeutics LSTA Stock Holding History

CSS LLC’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Buy	110,422 +48,524	+78%	+$173K	0.01%	628
2026 Q1	$310K	Buy	+61,898	New	+$256K	0.01%	644

Other funds holding LSTA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CSS LLC's LSTA Position: Q2 2026 in Review

CSS LLC increased its Lisata Therapeutics (LSTA) stake by 78% in Q2 2026, buying an estimated $173K and bringing the position to 110,422 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #628.

CSS LLC first reported a position in LSTA in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

CSS LLC held 110,422 shares of Lisata Therapeutics worth $375K as of Q2 2026.
CSS LLC bought 48,524 Lisata Therapeutics shares in Q2 2026, an estimated $173K.
Lisata Therapeutics made up 0.01% of CSS LLC's portfolio in Q2 2026, its #628 holding.
CSS LLC first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 2 quarters since.
31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.